FolioLanternBeta
MPLTMapLight Therapeutics, Inc.

Martin Babler

Director at MapLight Therapeutics, Inc., as of Jun 25, 2026No sales or purchases in the past 12 months.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
7.9K
shares held after the latest filing, MapLight Therapeutics, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
2
companies filed for

Last filing: Jun 25, 2026. Most recent purchase on record: Apr 1, 2025.

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
MapLight Therapeutics, Inc. (MPLT)DirectorJun 25, 2026Jun 25, 2026
Alumis Inc. (ALMS)President, CEO and Chairman, DirectorJun 27, 2024Jan 28, 2026

Also a director at

Alumis Inc. (ALMS)

Recent filings

The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.